RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-September
Published on: April 30, 2026, 11:41 p.m. | Source: The Economic Times
RPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company also aims to enter the GLP-1 weight-loss therapy market by August-September. Despite geopolitical risks, RPG Life Sciences is strategically focusing on niche, complex molecules and expanding into new therapy areas.
